·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ °¿øµµ¾à ÃÖÁ¾ ÅõÇ¥À² 81.2%¡¦615¸í Âü¿© ±â»çÀÔ·Â : 09.12.10 18:21:03 0 °¡ ÇÃÄ£Ãß°¡ °¿øµµ¾à»çȸÀå ¼±°Å ÃÖÁ¾ ÅõÇ¥À²ÀÌ 81.2%·Î Áý°èµÆ´Ù. µµ¾à»çȸ ¼±°üÀ§¿¡ µû¸£¸é ¿ÀÈÄ ¾à»çȸÀå ¼±°Å ÅõÇ¥°¡ ÃÖÁ¾ ¸¶°¨µÈ °á°ú 757¸í °¡¿îµ¥ 615¸íÀÌ ÅõÇ¥¸¦ ¸¶ÃÆ´Ù. ±èÁؼö Èĺ¸¿Í Çϼ®±Õ È帰¡ °æ¼±ÁßÀÎ °¿øµµ ¾à»çȸÀå ¼±°Å ÅõÇ¥ÇÔÀº 6½Ã 30ºÐºÎÅÍ °³ºÀµÉ ¿¹Á¤ÀÌ´Ù. X AD Á¾¼Ò¼¼ °£Æí°è»ê GO À̺¥Æ®Âü¿© ¡æ ÀÌÇöÁÖ ±âÀÚ(lhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Sr. RA Specialist & RA Specialist (2 Year Contract) ¹Ù·Î°¡±â °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â 2025³â »ó¹Ý±â ¼ö½Ãä¿ë(ÇмúÀÇÇнÇ, BDÆÀ ¾à»ç) ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë ¹Ù·Î°¡±â [Çѵ¶] Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®, MA, Ãѹ« ÆÀÀå, Á¦Á¶°ü¸® ¾à»ç, ÀÌÈÇнÃÇè(QC), ±â¼úÆÀ ±³Á¤´ã´ç, Àü¹®ÀǾàǰ ¸¶ÄÉÆÃ, ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ ¹Ù·Î°¡±â RA, PMS, MSL ,PM, MR, MM µî °¢ ºÎ¹® ¸ðÁý ¹Ù·Î°¡±â R&D¼¾ÅÍ ¿¬±¸¿ø ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °¿øµµ¾à ÃÖÁ¾ ÅõÇ¥À² 81.2%¡¦615¸í Âü¿© URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ °¿øµµ¾à ÃÖÁ¾ ÅõÇ¥À² 81.2%¡¦615¸í Âü¿© ±â»çÀÔ·Â : 09.12.10 18:21:03 0 °¡ ÇÃÄ£Ãß°¡ °¿øµµ¾à»çȸÀå ¼±°Å ÃÖÁ¾ ÅõÇ¥À²ÀÌ 81.2%·Î Áý°èµÆ´Ù. µµ¾à»çȸ ¼±°üÀ§¿¡ µû¸£¸é ¿ÀÈÄ ¾à»çȸÀå ¼±°Å ÅõÇ¥°¡ ÃÖÁ¾ ¸¶°¨µÈ °á°ú 757¸í °¡¿îµ¥ 615¸íÀÌ ÅõÇ¥¸¦ ¸¶ÃÆ´Ù. ±èÁؼö Èĺ¸¿Í Çϼ®±Õ È帰¡ °æ¼±ÁßÀÎ °¿øµµ ¾à»çȸÀå ¼±°Å ÅõÇ¥ÇÔÀº 6½Ã 30ºÐºÎÅÍ °³ºÀµÉ ¿¹Á¤ÀÌ´Ù. X AD Á¾¼Ò¼¼ °£Æí°è»ê GO À̺¥Æ®Âü¿© ¡æ ÀÌÇöÁÖ ±âÀÚ(lhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Sr. RA Specialist & RA Specialist (2 Year Contract) ¹Ù·Î°¡±â °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â 2025³â »ó¹Ý±â ¼ö½Ãä¿ë(ÇмúÀÇÇнÇ, BDÆÀ ¾à»ç) ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë ¹Ù·Î°¡±â [Çѵ¶] Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®, MA, Ãѹ« ÆÀÀå, Á¦Á¶°ü¸® ¾à»ç, ÀÌÈÇнÃÇè(QC), ±â¼úÆÀ ±³Á¤´ã´ç, Àü¹®ÀǾàǰ ¸¶ÄÉÆÃ, ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ ¹Ù·Î°¡±â RA, PMS, MSL ,PM, MR, MM µî °¢ ºÎ¹® ¸ðÁý ¹Ù·Î°¡±â R&D¼¾ÅÍ ¿¬±¸¿ø ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °¿øµµ¾à ÃÖÁ¾ ÅõÇ¥À² 81.2%¡¦615¸í Âü¿© URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ °¿øµµ¾à ÃÖÁ¾ ÅõÇ¥À² 81.2%¡¦615¸í Âü¿© ±â»çÀÔ·Â : 09.12.10 18:21:03 0 °¡ ÇÃÄ£Ãß°¡ °¿øµµ¾à»çȸÀå ¼±°Å ÃÖÁ¾ ÅõÇ¥À²ÀÌ 81.2%·Î Áý°èµÆ´Ù. µµ¾à»çȸ ¼±°üÀ§¿¡ µû¸£¸é ¿ÀÈÄ ¾à»çȸÀå ¼±°Å ÅõÇ¥°¡ ÃÖÁ¾ ¸¶°¨µÈ °á°ú 757¸í °¡¿îµ¥ 615¸íÀÌ ÅõÇ¥¸¦ ¸¶ÃÆ´Ù. ±èÁؼö Èĺ¸¿Í Çϼ®±Õ È帰¡ °æ¼±ÁßÀÎ °¿øµµ ¾à»çȸÀå ¼±°Å ÅõÇ¥ÇÔÀº 6½Ã 30ºÐºÎÅÍ °³ºÀµÉ ¿¹Á¤ÀÌ´Ù. X AD Á¾¼Ò¼¼ °£Æí°è»ê GO À̺¥Æ®Âü¿© ¡æ ÀÌÇöÁÖ ±âÀÚ(lhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °¿øµµ¾à ÃÖÁ¾ ÅõÇ¥À² 81.2%¡¦615¸í Âü¿© URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö